Evidence map›Paper›PMID 17116883›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms.

Hirotoshi Matsui, Victoria E Wagner, David B Hill, Ute E Schwab, Troy D Rogers, Brian Button, Russell M Taylor, Richard Superfine, Michael Rubinstein, Barbara H Iglewski and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
9.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 235 citations in OpenAlex.

  1. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2012
    Trial
  2. Article
  3. Article
  4. Article
  5. Interspecific comparisons of anuran embryonic epidermal landscapes and energetic trade-offs in response to changes in salinity.Developmental dynamics : an official publication of the American Association of Anatomists · 2025
    Article
  6. Spatial self-organization of confined bacterial suspensions.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Biopolymeric Inhalable Dry Powders for Pulmonary Drug Delivery.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Journal of biomedical optics · 2024
    Article
  14. Metapopulation model of phage therapy of an acutebioRxiv : the preprint server for biology · 2024
    Article
  15. Frontiers in immunology · 2024
    Review
  16. Article
  17. Article
  18. EngineeringJournal of materials chemistry. B · 2023
    Article
  19. Article
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Hirotoshi MatsuiCystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, NC 27599, USA.
Victoria E Wagner
David B Hill
Ute E Schwab
Troy D Rogers
Brian Button
Russell M Taylor
Richard Superfine
Michael Rubinstein
Barbara H Iglewski
Richard C Boucher
Rockefeller University · USUniversity of Rochester · USUniversity of North Carolina at Chapel Hill · US

Funding

INTERACTIVE GRAPHICS FOR MOLECULAR STUDIES &MICROSCOPYP41EB002025 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUPERFINE, RICHARD · 2003 to 2019
$16.9M
THE BIOLOGY OF MUCUS AND MUCUS PLAQUES ON CF AIRWAYSP50HL060280 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RIORDAN, JOHN · 1998 to 2007
$14.0M
Combinatorial Optimization of Protein BiosensorsR01EB000205 · NIBIB · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI DAUGHERTY, PATRICK S · 2002 to 2006
$1.0M
NHLBI NIH HHS HL33242NHLBI NIH HHS P50 HL060280NIAID NIH HHS R37 AI37713NIBIB NIH HHS P41 EB002025NIBIB NIH HHS P41 EB00205-21
6 · The paper itself

Abstract

A vexing problem in cystic fibrosis (CF) pathogenesis has been to explain the high prevalence of Pseudomonas aeruginosa biofilms in CF airways. We speculated that airway surface liquid (ASL) hyperabsorption generates a concentrated airway mucus that interacts with P. aeruginosa to promote biofilms. To model CF vs. normal airway infections, normal (2.5% solids) and CF-like concentrated (8% solids) mucus were prepared, placed in flat chambers, and infected with an approximately 5 x 10(3) strain PAO1 P. aeruginosa. Although bacteria grew to 10(10) cfu/ml in both mucus concentrations, macrocolony formation was detected only in the CF-like (8% solids) mucus. Biophysical and functional measurements revealed that concentrated mucus exhibited properties that restrict bacterial motility and small molecule diffusion, resulting in high local bacterial densities with high autoinducer concentrations. These properties also rendered secondary forms of antimicrobial defense, e.g., lactoferrin, ineffective in preventing biofilm formation in a CF-like mucus environment. These data link airway surface liquid hyperabsorption to the high incidence of P. aeruginosa biofilms in CF via changes in the hydration-dependent physical-chemical properties of mucus and suggest that the thickened mucus gel model will be useful to develop therapies of P. aeruginosa biofilms in CF airways.

Indexed as

BiofilmsCells, CulturedChemical PhenomenaChemistry, PhysicalCystic FibrosisGelsHumansMucusPseudomonas aeruginosaPseudomonas InfectionsSolutionsWaterGelsSolutionsWater

Identifiers

PMID17116883
PMCPMC1838718
OpenAlexW2146842734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.